- Report
- June 2025
- 182 Pages
United States
From €5385EUR$5,995USD£4,600GBP
- Report
- June 2025
- 130 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- June 2025
- 140 Pages
Japan
From €1374EUR$1,530USD£1,174GBP
€1617EUR$1,800USD£1,381GBP
- Report
- May 2025
- 191 Pages
Global
From €4446EUR$4,950USD£3,798GBP
- Report
- May 2025
- 102 Pages
Global
From €2650EUR$2,950USD£2,263GBP
- Report
- May 2025
- 76 Pages
Africa, Middle East
From €2650EUR$2,950USD£2,263GBP
- Report
- May 2025
- 80 Pages
From €2650EUR$2,950USD£2,263GBP
- Report
- May 2025
- 95 Pages
Asia Pacific
From €3099EUR$3,450USD£2,647GBP
- Report
- May 2025
- 98 Pages
Europe
From €3099EUR$3,450USD£2,647GBP
- Report
- May 2025
- 88 Pages
North America
From €2650EUR$2,950USD£2,263GBP
- Report
- April 2025
- 210 Pages
Global
From €4042EUR$4,500USD£3,453GBP
- Report
- April 2025
- 220 Pages
Global
From €4042EUR$4,500USD£3,453GBP
- Report
- April 2025
- 180 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- March 2025
- 131 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- February 2025
- 130 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- January 2025
- 60 Pages
Global
From €4486EUR$4,995USD£3,832GBP
- Report
- December 2024
- 164 Pages
Global
From €4486EUR$4,995USD£3,832GBP
- Report
- November 2024
- 150 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- October 2024
- 141 Pages
Poland
From €1374EUR$1,530USD£1,174GBP
€1617EUR$1,800USD£1,381GBP
- Report
- October 2024
- 70 Pages
Asia Pacific
From €853EUR$950USD£729GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more